Form 4: Tenon Medical Director Converts RSUs to Common Stock

Tenon Medical Director Kristine M. Jacques converted 10,729 Restricted Stock Units into common stock on January 1, 2026.

Summary

• Kristine M. Jacques, a Director of Tenon Medical, Inc. (TNON), reported changes in her beneficial ownership.
• On January 1, 2026, 10,146 Restricted Stock Units (RSUs) granted on October 13, 2025, were converted into 10,146 shares of Tenon Medical common stock.
• Additionally, 583 RSUs granted on May 8, 2024, were converted into 583 shares of Tenon Medical common stock on the same date.
• Following these conversions, Kristine M. Jacques directly beneficially owns a total of 10,729 shares of Tenon Medical, Inc. common stock.
• Kristine M. Jacques continues to hold 10,147 Restricted Stock Units from the October 13, 2025 grant and 492 Restricted Stock Units from the May 8, 2024 grant, representing contingent rights to receive common stock.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as it reflects the vesting of equity compensation for a director, which is a routine and expected event. It indicates continued alignment of the director's interests with the company's stock performance.

Positives

• The conversion of Restricted Stock Units into common stock increases the direct ownership stake of a company director, potentially aligning their interests more closely with shareholders.
• The vesting and conversion of RSUs represent a successful realization of equity compensation for the director.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This is a routine insider transaction filing (Form 4) and does not provide specific insights into broader industry trends or competitive landscape for Tenon Medical, Inc. It reflects standard equity compensation practices for corporate directors.

Stakeholder Impact

• Shareholders: The conversion of RSUs into common stock results in a minor increase in the outstanding share count, which is a standard aspect of equity compensation plans. It also increases the direct ownership of a director, potentially enhancing alignment with shareholder interests.
• Employees (specifically the reporting person): The director has realized value from their equity compensation, which is a positive outcome for the individual.

Key Dates

Keywords

Tenon Medical, TNON, Kristine M. Jacques, Form 4, insider transaction, director, restricted stock units, RSU conversion, common stock, beneficial ownership